TickerFactsScreenerDevelopers

Gain Therapeutics, Inc. (GANX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2021: $94.2K2022: $119.0K2023: $15.4K2024: $22.5K$22.5K
2021Capital Expenditures (USD)2024
Fiscal YearCapital ExpendituresChange YoY
2024$22.5K+46.5%
2023$15.4K-87.1%
2022$119.0K+26.3%
2021$94.2K—